4.6 Article

Humoral Immune Responses to P. falciparum Circumsporozoite Protein (Pfcsp) Induced by the RTS, S Vaccine-Current Update

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

How to induce protective humoral immunity against Plasmodium falciparum circumsporozoite protein

Ilka Wahl et al.

Summary: This review summarizes our understanding of the molecular and cellular immune responses to Plasmodium falciparum circumsporozoite protein (PfCSP) in humans, and discusses the implications for vaccine design. However, the current efficacy of anti-PfCSP vaccine responses is limited. Therefore, this article reviews recent research efforts and discusses ways to overcome these limitations to improve vaccine effectiveness and long-term protection.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Parasitology

Characterization of Anopheles gambiae D7 salivary proteins as markers of human-mosquito bite contact

Brenda Oseno et al.

Summary: This study evaluates the utility of IgG responses to members of the Anopheles gambiae D7 protein family as serological markers of human-vector contact. The results show that the D7L2 salivary antigen has great potential as a biomarker of exposure to mosquito bites and as a tool for assessing the efficacy of vector control strategies.

PARASITES & VECTORS (2022)

Article Multidisciplinary Sciences

Bacillus subtilis spores as delivery system for nasal Plasmodium falciparum circumsporozoite surface protein immunization in a murine model

Maria Edilene M. de Almeida et al.

Summary: This study found that coupling Bacillus subtilis spores with the CSP protein of Plasmodium falciparum can enhance the immunogenicity of the antigen and induce a high level of antibody response. This research provides a promising direction for using Bacillus subtilis spores as an adjuvant in vaccine formulations.

SCIENTIFIC REPORTS (2022)

Article Cell Biology

The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria

Lawrence T. Wang et al.

Summary: L9 is a potent human monoclonal antibody that can bind to Plasmodium falciparum circumsporozoite protein (PfCSP) on malaria-infective sporozoites, aiding in the development of malaria vaccines. Understanding the ontogeny and binding mechanisms of L9 is crucial for neutralizing sporozoites.

CELL REPORTS (2022)

Article Immunology

Identification of a neutralizing epitope within minor repeat region of Plasmodium falciparum CS protein

J. Mauricio Calvo-Calle et al.

Summary: The study demonstrates differences in the ability of antibodies to recognize the major and minor repeats in the central repeat region of the CS protein. It highlights the importance of assessing the fine specificity and functions of anti-repeat antibodies elicited by P. falciparum CS-based vaccines and suggests that designing immunogens to increase antibody responses to minor CS repeats may enhance vaccine efficacy.

NPJ VACCINES (2021)

Article Infectious Diseases

Seven-year kinetics of RTS, S/AS01-induced anti-CSP antibodies in young Kenyan children

Robert M. Mugo et al.

Summary: RTS,S/AS01-induced antibodies exhibit rapid waning within 6.5 months post-vaccination, followed by a slower decay over subsequent years. The vaccine-induced antibodies remained elevated above control group levels throughout the 7 years follow-up period.

MALARIA JOURNAL (2021)

Article Multidisciplinary Sciences

Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum

Tossapol Pholcharee et al.

Summary: This study provides insights into the protective mechanism of antibodies targeting PfCSP for malaria vaccination, as well as guidance for designing more effective immunogens and passive immunization antibodies.

NATURE COMMUNICATIONS (2021)

Review Health Care Sciences & Services

Towards Eradication of Malaria: Is the WHO's RTS,S/AS01 Vaccination Effective Enough?

Navneet Arora et al.

Summary: The RTS,S/AS01 vaccine is safe and immunogenic in children, but has modest efficacy against clinical malaria and requires a booster dose for improved protection. Its cost-effectiveness and potential public health impact are being assessed for wider deployment.

RISK MANAGEMENT AND HEALTHCARE POLICY (2021)

Article Public, Environmental & Occupational Health

Overdiagnosis of Malaria Illness in an Endemic Setting: A Facility-Based Surveillance Study in Malawi

Ingrid Peterson et al.

Summary: In Malawi, high burden of malaria illness was found in children, with malaria accounting for about 50% of fevers in children under 5 years old and less than 20% in school-age children. This suggests a potential overdiagnosis of malaria and highlights the need for interventions to reduce malaria transmission and improve diagnostic clarity among outpatients in endemic settings.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)

Article Microbiology

The P. falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo

Yevel Flores-Garcia et al.

Summary: Human monoclonal antibodies targeting three different protective epitopes in the PfCSP repeat region can prevent malaria infection, with the junction and minor repeats identified as necessary and sufficient for neutralization, while major repeats are required for in vivo protection by certain antibodies. These findings support the development of vaccines targeting multiple epitopes to enhance antibody responses against malaria.

PLOS PATHOGENS (2021)

Article Immunology

Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity

Liriye Kurtovic et al.

Summary: Research suggests that different regions of the Plasmodium falciparum circumsporozoite protein (CSP) elicit distinct antibody responses, with individuals acquiring functional complement-fixing antibodies producing antibodies targeting specific regions. Complement-fixing antibodies mainly target the N-terminal, central-repeat, and C-terminal regions of CSP, with antibodies to these regions playing a role in mediating blood-stage red blood cell infection.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice

Liriye Kurtovic et al.

Summary: The study compared the traditional malaria vaccine RTS,S with a novel VLP that uses the small surface antigen of duck hepatitis B virus to display CSP. The new VLP does not require excess scaffold antigen, forming larger particles and increasing the proportion of CSP in the vaccine construct. Vaccine-induced antibodies demonstrated strong functional activities and exhibited similar properties to protective monoclonal antibodies.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

Multi-functional antibody profiling for malaria vaccine development and evaluation

D. Herbert Opi et al.

Summary: It is increasingly clear that multiple antibody effector functions play a role in immunity to malaria. Evaluating vaccine candidates should move beyond individual assays or measuring IgG magnitude alone, and instead incorporate a wider range of assays measuring functional antibody responses. A 3-tier approach to implementing assays to inform vaccine evaluation is proposed.

EXPERT REVIEW OF VACCINES (2021)

Article Infectious Diseases

The effect of community-driven larval source management and house improvement on malaria transmission when added to the standard malaria control strategies in Malawi: a cluster-randomized controlled trial

Robert S. McCann et al.

Summary: This study in Malawi conducted a 3-year cluster-randomized controlled trial, indicating that community-based house improvement and larval source management did not contribute to further reductions in malaria transmission or prevalence beyond the reductions observed with high rates of insecticide-treated bed net use.

MALARIA JOURNAL (2021)

Article Cell Biology

Functional human IgA targets a conserved site on malaria sporozoites

Joshua Tan et al.

Summary: This study demonstrates that circulating IgA plays a role in immunity to malaria, particularly in response to P. falciparum sporozoites. The research also identifies a specific target, the amino terminus of the circumsporozoite protein, for functional antibodies that reduce liver parasite burden.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Biotechnology & Applied Microbiology

RTS,S/AS01 vaccine (Mosquirix?): an overview

Matthew B. Laurens

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

Article Multidisciplinary Sciences

Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform

Mark D. Langowski et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Immunology

Role of Opsonophagocytosis in Immune Protection against Malaria

Wolfgang W. Leitner et al.

VACCINES (2020)

Article Multidisciplinary Sciences

Targets of complement-fixing antibodies in protective immunity against malaria in children

Linda Reiling et al.

NATURE COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

Neville K. Kisalu et al.

NATURE MEDICINE (2018)

Review Immunology

Correlating efficacy and immunogenicity in malaria vaccine trials

Matthew B. B. McCall et al.

SEMINARS IN IMMUNOLOGY (2018)

Article Medicine, General & Internal

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

Sara Mian-McCarthy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Infectious Diseases

Determinants of relapse periodicity in Plasmodium vivax malaria

Nicholas J. White

MALARIA JOURNAL (2011)

Article Medicine, General & Internal

First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

Selidji Todagbe Agnandji et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Immunology

C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria

ES Bergmann-Leitner et al.

INTERNATIONAL IMMUNOLOGY (2005)

Review Parasitology

Autoimmunity and malaria: what are they doing together?

CT Daniel-Ribeiro et al.

ACTA TROPICA (2000)